Richard H Scheller is Director of BridgeBio Pharma, Inc.. Currently has a direct ownership of 53,822 shares of BBIO, which is worth approximately $1.49 Million. The most recent transaction as insider was on Feb 16, 2023, when has been sold 1,304 shares (Common Stock) at a price of $12.64 per share, resulting in proceeds of $16,482. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.8K
0% 3M change
0% 12M change
Total Value Held $1.49 Million

RICHARD H SCHELLER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2023
SELL
Payment of exercise price or tax liability
$16,482 $12.64 p/Share
1,304 Reduced 2.37%
53,822 Common Stock
Feb 16 2023
BUY
Exercise of conversion of derivative security
-
3,196 Added 5.48%
55,126 Common Stock
Nov 16 2022
SELL
Payment of exercise price or tax liability
$10,661 $9.64 p/Share
1,106 Reduced 2.09%
51,930 Common Stock
Nov 16 2022
BUY
Exercise of conversion of derivative security
-
3,196 Added 5.68%
53,036 Common Stock
Aug 16 2022
SELL
Payment of exercise price or tax liability
$12,199 $11.08 p/Share
1,101 Reduced 2.16%
49,840 Common Stock
Aug 16 2022
BUY
Exercise of conversion of derivative security
-
3,196 Added 5.9%
50,941 Common Stock
May 16 2022
SELL
Payment of exercise price or tax liability
$8,829 $6.74 p/Share
1,310 Reduced 2.67%
47,745 Common Stock
May 16 2022
BUY
Exercise of conversion of derivative security
-
3,195 Added 6.11%
49,055 Common Stock
Aug 04 2021
SELL
Open market or private sale
$733,350 $53.23 p/Share
13,777 Reduced 23.1%
45,860 Common Stock
Aug 04 2021
BUY
Exercise of conversion of derivative security
$234,209 $17.0 p/Share
13,777 Added 18.77%
59,637 Common Stock
Dec 21 2020
SELL
Open market or private sale
$3,935,125 $65.15 p/Share
60,401 Reduced 56.84%
45,860 Common Stock
Dec 18 2020
SELL
Open market or private sale
$1,961,400 $65.38 p/Share
30,000 Reduced 22.02%
106,261 Common Stock
Dec 15 2020
SELL
Open market or private sale
$1,895,070 $60.27 p/Share
31,443 Reduced 18.75%
136,261 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$497,709 $17.0 p/Share
29,277 Added 14.86%
167,704 Common Stock

Also insider at

ORIC
Oric Pharmaceuticals, Inc. Healthcare
ALEC
Alector, Inc. Healthcare
ME
23andMe Holding Co. Healthcare
DICE
DICE Therapeutics, Inc. Healthcare
RHS

Richard H Scheller

Director
Palo Alto, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO